Article: Nanobac Pharmaceuticals Inc. Announces Independent Study That Shows Nanobacteria Promote Gallstones.

TAMPA, Fla. -- Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") today announced the publication by independent researchers of a proof of concept that calcifying nanoparticles, also known as nanobacteria, promote disease.

The company also announced it is initiating a project to validate the findings in its own experiments, to be completed by year-end 2006.

In "An Animal Model of Black Pigment Gallstones Caused by Nanobacteria" published in the June edition of the peer-reviewed journal Digestive Diseases and Sciences, Dr. Limin Wang et al from Shantou University Medical College, Guangdong, China, established that calcifying ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!